万孚生物：前三季度净利润1.34亿元 同比下降69.32%

Core Insights - Wanfu Biological (300482) reported a significant decline in revenue and net profit for Q3 2025, indicating ongoing financial challenges [1] Financial Performance - The company's Q3 2025 revenue was 445 million yuan, representing a year-on-year decrease of 26.66% [1] - For the first three quarters of 2025, the total revenue was 1.69 billion yuan, down 22.52% compared to the previous year [1] - The net profit for Q3 2025 was a loss of 55.46 million yuan, while the net profit for the first three quarters was 134 million yuan, reflecting a 69.32% decline year-on-year [1]